Obesity drug associated with increased cancer risk (1)

15 Jan 2020


The Food and Drug Administration have issued a public safety alert that warns of a potential increased risk for cancer with lorcaserin, a weight-management obesity drug.

Healio


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story